Baird Medical Investment Holdings Limited (BDMD)

NASDAQ: BDMD · Real-Time Price · USD

1.020

0.00 (0.00%)

At close: Jul 24, 2026, 4:00 PM EDT

1.030

+0.010 (0.98%)

After-hours: Jul 24, 2026, 7:37 PM EDT

BDMD Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	22.54	22.54	37.04	31.46	35.09	29.68
Revenue Growth	-29.26%	-39.15%	17.73%	-10.35%	18.22%	63.93%
Gross Profit	18.88	18.88	32.65	27.23	28.04	24.66
Operating Income	-25.63	-25.63	15.32	11.86	13.63	11.72
Net Income	-27.28	-27.28	12.45	10.55	12.57	11.67
Earnings Per Share	-0.98	-0.98	0.57	0.51	0.49	-
EPS Growth	-	-	11.77%	4.08%	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Sales of MWA Medical Devices	22.54	22.54	37.03	30.94	31.28	24.75
Sales of Other Medical Devices	-	-	0.01	0.52	3.81	4.36
Total	22.54	22.54	37.04	31.46	35.09	29.7

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2021	FY 2020
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Investments	0.18	0.18	2.97	1.51	3.28	1.07
Total Debt	19.3	19.3	20.88	11.51	2.86	3.68
Net Cash (Debt)	-19.12	-19.12	-17.91	-10	0.41	-2.61
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.69	-0.69	-0.82	-0.49	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-1.34	-1.34	-6.31	-1.02	0.49	7.25
Capital Expenditures	-0.04	-0.04	-2.85	-2.64	-5.91	-1.33
Free Cash Flow	-1.39	-1.39	-9.17	-3.66	-5.42	5.92
Free Cash Flow Growth	-	-	-	-	-	82.24%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	83.79%	83.79%	88.16%	86.56%	79.90%	83.08%
Operating Margin	-113.73%	-113.73%	41.35%	37.71%	38.85%	39.48%
Pretax Margin	-117.03%	-117.03%	38.04%	39.29%	41.38%	48.20%
Profit Margin	-122.20%	-122.20%	34.01%	33.88%	36.41%	39.68%
FCF Margin	-6.15%	-6.15%	-24.75%	-11.63%	-15.46%	19.95%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	13.33	21.00	20.94	-
PS Ratio	1.39	1.86	5.24	-	-	-